Rubicon Organics announced that Jesse McConnell has been appointed to the Company’s Board of Directors after receipt of security clearance from Health Canada. Mr. McConnell was elected to the Board by the shareholders at the Annual General Meeting on July 31, 2024, but his appointment to the Board was subject to being granted security clearance by Health Canada. Jesse McConnell was the Co-Founder of Rubicon Organics in 2015 and served as its Chief Executive Officer from May 20, 2015, to December 31, 2022. The Company has awarded a total of 140,459 Deferred Share Units under its Omnibus Equity Incentive Plan to a director as compensation for their upcoming service. These DSUs will vest after twelve months from the grant date and can only be redeemed if the holder ceases to be a director of the Company or in accordance with the provisions of the Omnibus Equity Incentive Plan.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ROMJF:
- Rubicon Organics Announces Board Appointment and DSU Grant
- Rubicon Organics Flourishes in Q2 with Record Revenues
- Rubicon Organics anticipates year-over-year growth in net revenue in FY24
- Rubicon Organics Reports Q2 2024 Financial Results
- Rubicon Organics reports Q2 revenue C$12.1M vs. C$11.3M last year